Cited by 21Circadian rhythm and melatoninCOVID-19 and Mental HealthTreatment of Major Depression

Fluvoxamine, melatonin and COVID-19

Open access
Anderson, George M.·2021·Psychopharmacology

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00213-020-05753-z

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Fluvoxamine stimulates the sigma-1 receptor to reduce inflammatory response and nearly triples nocturnal plasma melatonin levels.

    “Fluvoxamine stimulates the sigma-1 receptor to reduce inflammatory response, but it also nearly triples nocturnal plasma levels of melatonin [53].”

    From Overview of sleep management during COVID-19. (2022) · cites this paper as [53]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Anderson, G. M.
Affiliations
Yale University (US)
Corresponding author
Anderson, George M.
Venue
Psychopharmacology
Published
2021-01-04
Volume
238
Issue
2
Pages
611-611
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W3120231206
Cited by
21
References
4
Citations by year
2025: 1 · 2024: 1 · 2023: 2 · 2022: 6 · 2021: 11
Type
journal article
Language
en
Open access
Locations
  • Psychopharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
  • Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
fluvoxamine, melatonin, COVID-19 pandemic, SARS-CoV-2, selective serotonin reuptake inhibitors, antiviral activity
MeSH terms
Clinical Deterioration, COVID-19, SARS-CoV-2, Humans, Melatonin, Outpatients, Fluvoxamine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review